This paper is only available as a PDF. To read, Please Download here.
Background. Surgical exploration for gastrinoma has a high failure rate because of small primary tumors and occult metastasis. Despite extensive preoperative and Intraoperative tumor localization, only 30% to 40% of patients with gastrinoma are cured by surgery. Two patients with unlocalized gastrinomas were studied with Intraoperative gamma detection of an iodine 125-labeled somatostatin analog, lanreotide, to localize their tumors.
Methods. Both patients were challenged before operation with 100 μg of octreotide acetate, and both had circulating gastrin levels suppressed by greater than 50%. Iodine 125-labeled lanreotide (100 to 150 μCi) was injected during exploration, and an Intraoperative gamma detector was used to detect tumor binding of the analog.
Results. In patient 1 a single source of increased counts was discovered in a retroduodenal lymph node, which was excised, no other tissue was removed. Histologic study of this node failed to demonstrate tumor; however, the patient's gastrin level was normal (63 pg/ml) 4 months after operation. In patient 2 five areas of increased counts were discovered and excised. Three of these five areas had visible tumor on microscopic examination. Three months after operation the patient's fasting gastrin level was 103 pg/ml.
Conclusions. Intraoperative gamma detection of radiolabeled peptides may allow the localization of occult tumors that contain specific peptide receptors.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Early surgical treatment of gastrinoma.Am J Med. 1987; 82: 17-24
- Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome.Gastroenterology. 1987; 92: 905-912
- Superselective arteriography of the pancreas.in: Anacker H. Efficacy and limitations of radiologic diagnosis of the pancreas. George Thieme Publishers, Stuttgart1975: 118-124
- Intraoperative ultrasonic localization of islet cell tumors: a prospective comparison to palpation.Ann Surg. 1988; 207: 160-168
- Long-term efficacy of octreotide in the treatment of Zollinger-Ellison syndrome.Arch Surg. 1992; 127: 1019-1026
- Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a handheld gamma-detecting probe.Surgery. 1993; 114: 745-752
- Receptor scintigraphy with a radioiodinated somatostatin analog: radiolabeling, purification, biologic activity, and in vivo application in animals.J Nucl Med. 1990; 31: 1501-1509
- Characterization of somatostatin receptors on human neuroblastoma tumor cell growth and differentiation.Cell Growth Differ. 1991; 5: 1-8
- A versatile computerized approach for the characterization of ligand binding systems.Anal Biochem. 1980; 107: 220-239
- Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC.J Pharmacol Methods. 1985; 14: 213-228
- Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.Ann Surg. 1986; 204: 468-478
- Evaluation of angiography in Zollinger-Ellison syndrome.Radiology. 1979; 131: 317-320
- Localization of endocrine-related tumors with radioiodinated analog of somatostatin.Lancet. 1989; 1: 242-244
- Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.Horm Metab Res Suppl. 1993; 27: 56-58
☆Supported in part by The Oregon Health Sciences University Surgical Endocrinology Development Fund.
☆☆Presented at the Fifteenth Annual Meeting of the American Association of Endocrine Surgeons, Dearborn, Mich., April 17–19, 1994.
© 1994 Published by Elsevier Inc.